Structure-activity relationship of fluoroquinolone in Escherichia coli

被引:6
作者
Lee, S
Park, T
Lee, Y
机构
[1] Seoul Womens Univ, Dept Biol, Seoul 139774, South Korea
[2] Korea Res Inst Chem Technol, Yusong Gu, Taejon 305343, South Korea
关键词
fluoroquinolone; Escherichia coli; structure-activity-relationship;
D O I
10.1007/BF02974013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-activity relationship of 20 fluoroquinolones was studied using the susceptible and 4 resistant Escherichia coli which were developed against 4 fluoroquinolones [ciprofloxacin (1), KR-10755 (6), norfloxacin (2), and ofloxacin (3)] in our laboratory. The C-7 and C-8 substituents of fluoroquinolone were important in various functions such as the inhibitory activity on DNA gyrase, permeability, and efflux. Among 20 fluoroquinolones, compounds with a 3-methyl-3,7-diazabicyclo[3.3.0]octan-1(5)-ene-7-yl substituent at the C-7 position or a chlorine substituent at the C-8 position showed a good inhibitory activity on DNA gyrase (especially a mutated DNA gyrase). Compounds With a 3,7-diazabicyclo [3.3.0]octan-1 (5)-ene-7-yI substituent at the C-7 position showed good permeability in the susceptible and resistant strains, while compounds with a fluorine substituent at the C-8 position were less effluxed from cells.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 17 条
[1]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE FLUOROQUINOLONES [J].
CHU, DTW ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :131-135
[2]   Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones [J].
Coll, R ;
GargalloViola, D ;
Tudela, E ;
Xicota, MA ;
Llovera, S ;
Guinea, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :274-277
[3]   PLACEMENT OF ALKYL SUBSTITUENTS ON THE C-7 PIPERAZINE RING OF FLUOROQUINOLONES - DRAMATIC DIFFERENTIAL-EFFECTS ON MAMMALIAN TOPOISOMERASE-II AND DNA GYRASE [J].
GOOTZ, TD ;
MCGUIRK, PR ;
MOYNIHAN, MS ;
HASKELL, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :130-133
[4]   MUTATIONS IN THE GYRA GENE OF A HIGHLY FLUOROQUINOLONE-RESISTANT CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
HEISIG, P ;
SCHEDLETZKY, H ;
FALKENSTEINPAUL, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) :696-701
[5]   DIFFERENCES IN SUSCEPTIBILITY TO QUINOLONES OF OUTER-MEMBRANE MUTANTS OF SALMONELLA-TYPHIMURIUM AND ESCHERICHIA-COLI [J].
HIRAI, K ;
AOYAMA, H ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :535-538
[6]   Norfloxacin resistance mechanism of E-coli 11 and E-coli 101 - Clinical isolates of Escherichia coli in Korea [J].
Kim, KS ;
Lee, SD ;
Lee, YH .
ARCHIVES OF PHARMACAL RESEARCH, 1996, 19 (05) :353-358
[7]   CONTRIBUTION OF THE C-8 SUBSTITUENT OF DU-6859A, A NEW POTENT FLUOROQUINOLONE, TO ITS ACTIVITY AGAINST DNA GYRASE MUTANTS OF PSEUDOMONAS-AERUGINOSA [J].
KITAMURA, A ;
HOSHINO, K ;
KIMURA, Y ;
HAYAKAWA, I ;
SATO, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1467-1471
[8]   N-1-tert-butyl-substituted quinolones: In vitro anti Mycobacterium avium activities and structure-activity relationship studies [J].
Klopman, G ;
Fercu, D ;
Renau, TE ;
Jacobs, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2637-2643
[9]  
LEE Y, 1992, Korean Biochemical Journal, V25, P134
[10]  
MITSCHER LA, 1989, QUINOLONES, P3